# Efficacy Study of CYT997 in Multiple Myeloma

> **NCT00664378** · PHASE2 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 5 (actual)

## Conditions studied

- Relapsed and Refractory Multiple Myeloma

## Interventions

- **DRUG:** CYT997

## Key facts

- **NCT ID:** NCT00664378
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Difficulty enrolling patients
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664378, "Efficacy Study of CYT997 in Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00664378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*